Product How it works Pricing Blog FAQ About Contact
Español English
EspañolEnglish
Log inCreate free account
Abbott Laboratories

Abbott Laboratories (NYSE: ABT) insider transactions

In the twelve months to 10 November 2026, executives and directors of Abbott Laboratories reported 12 open-market sales of 413,994 shares ($47.9m) and 6 open-market purchases of 43,000 shares ($4.4m), by 10 people, according to the Form 4 filings they submitted to the SEC.

Latest transactions

The 20 most recent transactions in Abbott Laboratories shares reported on Form 4
DateInsiderRoleTransactionSharesPriceHeld afterFiling
5 November 2026Moreland Mary KExecutive Vice PresidentOpen-market sale−3,500$116.00100,791Form 4
23 September 2026Conroy Kevin TDirectorShares withheld for tax−52,507$103.9981,230Form 4
2 September 2026McCoy John A. Jr.Vice President and ControllerOpen-market sale−27$109.5424,549Form 4
1 September 2026McCoy John A. Jr.Vice President and ControllerShares withheld for tax−52$110.3624,576Form 4
1 September 2026Boudreau Philip PEVP and CFOShares withheld for tax−388$110.3670,784Form 4
25 August 2026Ford Robert BChairman and CEOOption exercise+151,869$44.40458,330Form 4
25 August 2026Ford Robert BChairman and CEOOption exercise+246,963$59.94705,293Form 4
25 August 2026Ford Robert BChairman and CEOOpen-market sale−218,535$115.57486,758Form 4
25 August 2026Ford Robert BChairman and CEOOpen-market sale−180,297$116.19306,461Form 4
12 August 2026Morrone Louis H.Executive Vice PresidentDiscretionary transaction−12$107.990Form 4
11 August 2026Morrone Louis H.Executive Vice PresidentOpen-market sale−5,850$109.8370,724Form 4
30 June 2026Morrone Louis H.Executive Vice PresidentShares withheld for tax−269$92.7176,574Form 4
27 June 2026Cushman Elizabeth C.EVP, GC and SecretaryShares withheld for tax−560$94.1238,013Form 4
7 May 2026Stratton John GDirectorOpen-market purchase+2,000$86.8223,319Form 4
28 April 2026Moreland Mary KExecutive Vice PresidentDiscretionary transaction+5,314$94.4117,159Form 4
27 April 2026Starks Daniel JDirectorOpen-market purchase+10,000$92.656,751,103Form 4
24 April 2026Starks Daniel JDirectorGrant or award+2,286—6,741,103Form 4
24 April 2026McKinstry NancyDirectorGrant or award+2,286—41,010Form 4
24 April 2026Conroy Kevin TDirectorGrant or award+2,286—133,737Form 4
24 April 2026Stratton John GDirectorGrant or award+2,286—21,319Form 4

Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.

How to read the table

Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.

Where each row comes from

From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Abbott Laboratories page; the method, in data sources.

Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.